All In Biotech

Drug Trial Radar · NCT07766759

A Phase 1 Study of FXR0906 in Healthy Adults With or Without Elevated Triglycerides

A Single-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FXR0906 in Healthy Adult Participants With or Without Elevated Triglycerides

Last checked: Nov 19, 2026Latest source record: Aug 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Aug 25, 2026

Primary completion

Sep 24, 2027

Study completion Dec 20, 2027

Sponsor

Sponsor type
Industry
First posted
Aug 14, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics effects of a single dose of FXR0906 injection or placebo in Chinese healthy adult volunteers with or without TG increase.

Conditions

  • Healthy Adult Volunteers

Interventions

  • Intervention1: FXR0906 injectionDrug

    A single dose of FXR0906 (dose 1 ) will be administered on Day 1 by subcutaneous injection

  • Intervention2: FXR0906 injectionDrug

    A single dose of FXR0906 (dose 2) will be administered on Day 1 by subcutaneous injection

  • PlaceboDrug

    the volume mached placebo is normal saline (0.9%) and will be administered on Day 1.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. safetyTime frame: through study completion, an average of 26 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Peking University Third Hospital

    Beijing, Beijing Municipality, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.